# Efficacy and Safety of Bicifadine in the Treatment of Chronic Low Back Pain

> **NCT00295724** · PHASE3 · COMPLETED · sponsor: **DOV Pharmaceutical, Inc.**

## Conditions studied

- Chronic Low Back Pain

## Interventions

- **DRUG:** Bicifadine

## Key facts

- **NCT ID:** NCT00295724
- **Lead sponsor:** DOV Pharmaceutical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2007-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00295724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00295724, "Efficacy and Safety of Bicifadine in the Treatment of Chronic Low Back Pain". Retrieved via MORVS 2026-10-19 from https://api.morvs.ai/clinical/NCT00295724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*